NCT01497444
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +20 more
- Locations
-
- Mayo Clinic Scottsdale Scottsdale, Arizona, United States
- Mayo Clinic Cancer Center Rochester, Minnesota, United States
Clinical trial condition
Carcinoma
Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.
8,821 public trials
2,099 recruiting studies
Carcinoma trial results
Completed
Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma
NCT00779454
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +3 more
- Locations
-
- Vejle Hospital, Dept. of Oncology Vejle, Denmark
Completed
IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients
NCT03203005
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Universitair Ziekenhuis Antwerpen (UZA), Division of Gastroenterology and Hepatology Edegem, Belgium
- Universitätsklinik für Allgemeine, Viszeral- und Transplantationschirurgie Tübingen, Germany
- Istituto Nazionale Tumori "Pascale" (INTNA) Naples, Italy
- Ospedale Sacro Cuore-Don Calabria U.O.C. Oncologica Medica Negrar, Italy
Completed
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China
NCT03059641
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +14 more
- Locations
-
- The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
- First Hospital of Jilin University Changchun, China
- Sir Run Run Shaw Hospital, Zhejiang University School of medicine Hangzhou, China
- The First Hospital of Zhejiang Province Hangzhou, China
NCT03109457
- Conditions
- Blood-Borne Infections, Carcinoma, Carcinoma, Squamous Cell, +16 more
- Locations
-
- Kasr ALini Hospital Giza, Cairo Governorate, Egypt
NCT02240433
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Suita-shi, Japan
NCT01816841
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +15 more
- Locations
-
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States
NCT03804593
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +16 more
- Locations
-
- USC Keck Medical Center Los Angeles, California, United States
- California Liver Research Institute Pasadena, California, United States
NCT00895349
- Conditions
- Adenocarcinoma, Adenosquamous Carcinoma, Carcinoma, +21 more
- Locations
-
- Juravinski Cancer Centre Hamilton, Ontario, Canada
- London Health Sciences Centre - London Regional Cancer Program London, Ontario, Canada
- Ottawa Hospital Regional Cancer Centre Ottawa, Ontario, Canada
- Thunder Bay Regional Health Sciences Centre Thunder Bay, Ontario, Canada
NCT01926236
- Conditions
- Adenocarcinoma, Ampullary Cancer, Biliary Tract Cancer, +13 more
- Locations
-
- Queen Elizabeth Hospital Birmingham, United Kingdom
- Bristol Haematology & Oncology Centre Bristol, United Kingdom
- North Cumbria University Hospitals Carlisle, United Kingdom
- Beatson West of Scotland Cancer Centre Glasgow, United Kingdom